Holdings

ADAR1 Capital Management, LLC

As of Sep 30, 2026, ADAR1 Capital Management, LLC reported 238 positions worth US$2.22B. Largest: Abivax SA, State Street SPDR S&P 500 ETF and Protagonist Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Abivax SA2.05MUS$203M+246KSep 30, 2026
State Street SPDR S&P 500 ETF178KUS$135MnewSep 30, 2026
Protagonist Therapeutics, Inc.951KUS$134M−9,460Sep 30, 2026
Roivant Sciences Ltd.3.08MUS$113M−77,482Sep 30, 2026
Zai Lab Ltd.3.38MUS$89.1M+12,330Sep 30, 2026
Immunovant, Inc.2.12MUS$71.5M−215KSep 30, 2026
Xenon Pharmaceuticals Inc.1.16MUS$43.2M+995KSep 30, 2026
Denali Therapeutics Inc.2.07MUS$42.8M+1.04MSep 30, 2026
Alpha Architect 1-3 Month Box ETF337KUS$39.9MnewSep 30, 2026
Septerna, Inc.974KUS$38.1M+33,649Sep 30, 2026